Primary Site >> Liver Cancer
Gene >> NPC1L1
| 1. | |||||||||||
| Journal: | BMC Pharmacol. 2009 Aug 29;9:10. | ||||||||||
| Title: | Psychotropic drugs up-regulate the expression of cholesterol transport proteins including ApoE in cultured human CNS- and liver cells. | ||||||||||
| Author: | Vik-Mo, Audun O|Ferno, Johan|Skrede, Silje|Steen, Vidar M | ||||||||||
| PMID: | 19715613 | ||||||||||
| 2. | |||||||||||
| Journal: | J Virol. 2014 May;88(9):5050-61. | ||||||||||
| Title: | Determining the involvement and therapeutic implications of host cellular factors in hepatitis C virus cell-to-cell spread. | ||||||||||
| Author: | Barretto, Naina|Sainz, Bruno Jr|Hussain, Snawar|Uprichard, Susan L | ||||||||||
| PMID: | 24554660 | ||||||||||
| 3. | |||||||||||
| Journal: | Antiviral Res. 2015 Mar;115:94-104. | ||||||||||
| Title: | SKI-1/S1P inhibitor PF-429242 impairs the onset of HCV infection. | ||||||||||
| Author: | Blanchet, Matthieu|Sureau, Camille|Guevin, Carl|Seidah, Nabil G|Labonte, Patrick | ||||||||||
| PMID: | 25573299 | ||||||||||
| 4. | |||||||||||
| Journal: | ACS Infect Dis. 2015 Sep 11;1(9):420-7. | ||||||||||
| Title: | Targeting Viral Entry for Treatment of Hepatitis B and C Virus Infections. | ||||||||||
| Author: | Colpitts, Che C|Verrier, Eloi R|Baumert, Thomas F | ||||||||||
| PMID: | 27617925 | ||||||||||
| 5. | |||||||||||
| Journal: | Int J Infect Dis. 2016 Dec;53:6-11. | ||||||||||
| Title: | Genetic variations of the NPC1L1 gene associated with hepatitis C virus (HCV) infection and biochemical characteristics of HCV patients in China. | ||||||||||
| Author: | Zhang, A-Mei|Zhang, Cheng-Lin|Song, Yuzhu|Zhao, Ping|Feng, Yue|Wang, Binghui|Li, Zheng|Liu, Li|Xia, Xueshan | ||||||||||
| PMID: | 27769799 | ||||||||||
| 6. | |||||||||||
| Journal: | Med Hypotheses. 2017 May;102:51-55. | ||||||||||
| Title: | Hepatitis C virus may have an entero-hepatic cycle which could be blocked with ezetimibe. | ||||||||||
| Author: | Monrroy, Hugo|Lopez-Lastra, Marcelo|Soza, Alejandro | ||||||||||
| PMID: | 28478831 | ||||||||||
| 7. | |||||||||||
| Journal: | Curr Pharm Des. 2017;23(27):3941-3951. | ||||||||||
| Title: | Emerging Targets to Relieve Fat Stress-Induced Liver Diseases: UDCA, Tocotrienol, omega-3 PUFAs, and IgY Targeted NPC1L1 Cholesterol Transporter. | ||||||||||
| Author: | Cha, Ji-Young|Park, Jong-Min|Lee, Ho-Jae|Bae, Jin-Sik|Han, Young-Min|Oh, Byung-Chul|Ko, Kwang Hyun|Hahm, Ki-Baik | ||||||||||
| PMID: | 28714405 | ||||||||||